바이오테크 보도자료
-
- Icure Acquires Drug Product Approval for World’s First Donepezil Patch for Treating Dementia of the Alzheimer Type in Korea
- Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of Alzheimer’s-type dementia, received a drug product approval from the Ministry of Food and Drug Safety of Kor...
- 2021년 11월 17일
-
- BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA
- In 2009, AOP Orphan in-licensed the exclusive rights for clinical development and commercialization of Ropeginterferon alfa-2b in Polycythaemia Vera (PV), a rare disease, and other myeloproliferative neoplasms (MPNs) for European, Commonwealth of ...
- 2021년 11월 16일
-
- Theramex Enters OTC Market with Femarelle®, a Non-hormonal Option to Treat Menopause Symptoms
- Theramex, a company dedicated women’s health, recently acquired the Femarelle® product licence to treat menopause symptoms. Femarelle will be available in different markets from the 2nd quarter of 2022. This commercialisation agreement was reached...
- 2021년 11월 16일
-
- Aimmune Therapeutics Presents New PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Data on Immunological Outcomes of Long-Term Daily Oral Immunotherapy at the EAACI PAAM Digital Meeting
- Aimmune Therapeutics, Inc., a Nestlé Health Science company developing and commercializing pharmaceutical therapies to prevent, manage, and treat food and metabolic-related diseases, today presented results from longitudinal analyses evaluating im...
- 2021년 11월 15일
-
- VFMCRP receives positive CHMP opinion for Tavneos® for the treatment of ANCA-associated vasculitis
- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced that the European Medicines Agency’s (EMA) CHMP has recommended approval of Tavneos® (avacopan) in combination with a ri...
- 2021년 11월 12일
-
- Nuritas™ Raises $45 Million To Scale Its Peptide Discovery Platform And Expand Globally
- Nuritas, a biotechnology company revolutionizing the discovery and development of plant-based bioactive peptides, has closed a $45 million USD Series B funding round. The investment, led by Chicago-based Cleveland Avenue, LLC, includes Grosvenor’s...
- 2021년 11월 12일
-
- XPRIZE and Musk Foundation Name 23 Winners in Five Million Dollar Carbon Removal Student Competition
- XPRIZE, the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges, today announced that 23 student-led teams have won the $5M Carbon Removal Student Competition. The award program, which...
- 2021년 11월 11일
-
- Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology
- Yokogawa Electric Corporation (TOKYO:6841) announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services. Fostering the development of the...
- 2021년 11월 09일
-
- CORRECTING and REPLACING IPACKCHEM to Acquire and Partner With Mullackal
- CORRECTION...by Business Wire PARIS--(BUSINESS WIRE)-- Fourth paragraph, first sentence of release should read: “We are extremely excited to partner with Ramesh and Karthik Pillai...” (instead of “We are extremely excited to partner with Reams and...
- 2021년 11월 09일
-
- HKSTP Hosts Global Entrepreneurs at First-Ever Hybrid Elevator Pitch Competition to Spark a Week of GBA and International Business Opportunities
- Hong Kong Science and Technology Parks Corporation (HKSTP) today held its first-ever hybrid Elevator Pitch Competition (EPiC), with over 600 startups from Hong Kong and around the world joining the annual signature event. HKSTP is approaching 20 y...
- 2021년 11월 08일
전시회
